From: Dysferlinopathy in Switzerland: clinical phenotypes and potential founder effects
Family-patient | Exon/Intron | DNA | Effect of mutation |
---|---|---|---|
A-1 | ex12 | c.1064_1065delAA | p.Lys355ArgfsX4 |
 | ex23 | c.2217C>A | p.Tyr739X |
A-2 | ex12 | c.1064_1065delAA | p.Lys355ArgfsX4 |
 | ex23 | c.2217C>A | p.Tyr739X |
B-3 | ex12 | c.1064/1065delAA | p.Lys355ArgfsX4 |
 | ex25-27 |  | Deletion exon 25-27 |
C-4 | IVS28 | c. 3031 + 2T>C | Abn. Spli. |
 | IVS28 | c. 3031 + 2T>C | Abn. Spli. |
C-5 | IVS28 | c. 3031 + 2T>C | Abn. Spli. |
 | IVS28 | c. 3031 + 2T>C | Abn. Spli. |
C-6 | IVS28 | c. 3031 + 2T>C | Abn. Spli. |
 | ex27 | c. 2869C>T | p.Gln957X |
C-7 | IVS28 | c. 3031 + 2T>C | Abn. Spli. |
 | IVS28 | c. 3031 + 2T>C | Abn. Spli. |
C-8 | IVS28 | c.3031 + 2T>C | Abn. Spli |
 | IVS28 | c.3031 + 2T>C | Abn. Spli |
D-9 | IVS28 | c. 3031 + 2T>C | Abn. Spli. |
 | IVS28 | c. 3031 + 2T>C | Abn. Spli. |
D-10 | IVS28 | c. 3031 + 2T>C | Abn. Spli. |
 | IVS28 | c. 3031 + 2T>C | Abn. Spli. |
D-11 | IVS28 | c. 3031 + 2T>C | Abn. Spli. |
 | IVS28 | c. 3031 + 2T>C | Abn. Spli. |
E-13 | Ex53 | c.5928G>A | p.Trp1976Stop |
 | Ex53 | c.5928G>A | p.Trp1976Stop |
F-13 | IVS28 | c. 3031 + 2T>C | Abn. Spli. |
 | IVS28 | c. 3031 + 2T>C | Abn. Spli. |